Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis

Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone

(2011) Elizabeth Ducat et al.   ADDICTION BIOLOGY

Pharmacogenetics of alcohol, nicotine and drug addiction treatments

(2011) Jessica E. Sturgess et al.   ADDICTION BIOLOGY

The Effect of Naltrexone on Alcohol’s Stimulant Properties and Self-Administration Behavior in Social Drinkers: Influence of Gender and Genotype

(2011) Elaine Setiawan et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence

(2011) Janet K. Coller et al.   Pharmacogenetics and Genomics

Pharmacogenetics of Alcohol and Alcohol Dependence Treatment

(2010) Henry R. Kranzler et al.   CURRENT PHARMACEUTICAL DESIGN

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators

(2009) Wendy Ooteman et al.   ADDICTION BIOLOGY

Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers

(2008) Albert J. Arias et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non-Natives Residing in Rural Settings: A Randomized Controlled Trial

(2008) Stephanie S. OMalley et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence

(2008) Raymond F. Anton et al.   ARCHIVES OF GENERAL PSYCHIATRY

A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

(2008) Sung-Gon Kim et al.   PSYCHOPHARMACOLOGY